W Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
W Advisors's LLY Position: Q3 2026 in Review
W Advisors increased its Eli Lilly (LLY) stake by 0.38% in Q3 2026, buying an estimated $2.36K and bringing the position to 535 shares worth $619K. The position accounts for 0.27% of the portfolio, ranked #75.
W Advisors first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. The position peaked at $639K in Q2 2026. 4,162 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- W Advisors held 535 shares of Eli Lilly worth $619K as of Q3 2026.
- W Advisors bought 2 Eli Lilly shares in Q3 2026, an estimated $2.36K.
- Eli Lilly made up 0.27% of W Advisors's portfolio in Q3 2026, its #75 holding.
- W Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
- W Advisors's Eli Lilly position peaked at $639K in Q2 2026.
- 4,162 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on W Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.